Status:
COMPLETED
Vitamin D Supplementation in Kidney Disease
Lead Sponsor:
VA Office of Research and Development
Conditions:
Renal Dialysis
Vitamin D Deficiency
Eligibility:
All Genders
45-89 years
Phase:
NA
Brief Summary
This is a double-blind placebo controlled pilot study to determine if vitamin D supplementation in hemodialysis (HD) patients will improve physical function and cognition. HD patients have a high prev...
Detailed Description
Patients will first be identified based on the inclusion criteria, then informed about the study and consented. Those who meet the exclusion criteria will be randomized to treatment or placebo. Enroll...
Eligibility Criteria
Inclusion
- Receiving HD for at least two weeks
- Receiving IV vitamin D supplementation according to National Kidney Foundation guidelines.
- Male or female with an between the ages of 45-89 years
- Veteran outpatient or stable community living center patient
- Able to ambulate independently or with an assistive device for at least 20 feet
Exclusion
- 25-OH vitamin D level \< 25 ng/ml
- Hypercalcemia
- Active malignancy within 6 months
- Receiving intravenous antibiotics for infection
- History of Dementia
- Hemoglobin \< 8.5g
- History of conditions that interfere with postural instability (e.g. cerebellar disease, vestibular disease or any others that may present)
- Poor compliance with dialysis treatments (history of skipping 2 treatments per month for \> 2 months)
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01229878
Start Date
December 1 2011
End Date
December 30 2022
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, United States, 10468